Page 271 - Haematologica Vol. 107 - September 2022
P. 271

LETTER TO THE EDITOR
References
1. Chang JS, Zhou M, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1736-1740.
2. Francis SS, Wallace AD, Wendt GA, et al. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017;129(12):1680-1684.
3. Sooregard SH, Rostgaard K, Skogstrand K, Wiemels J, Schmiegelow K, Hjalgrim H. Neonatal inflammatory markers in children later diagnosed with B-cell precursor acute lymphoblastic leukaemia. Cancer Res. 2018;78(18):5458-5463.
4. Whitehead TP, Wiemels JL, Zhou M, et al. Cytokine levels at birth in children who developed acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2021;30(8):1526-1535.
5. Wiemels JL, Talback M, Francis S, Feychting M. Early infection with cytomegalovirus and risk of childhood hematologic malignancies. Cancer Epidemiol Biomarkers Prev. 2019;(6):1024-1027.
6. Kharrazi M, Pearl M, Yang J, et al. California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study. Paediatr Perinat Epidemiol. 2012;(3):250-263.
7. Nielsen AB, Zhou M, de Smith AJ, et al. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology. Haematologica. 2019;104(11):e514-e516.
8. Young VP, Mariano MC, Faure L, Spencer JV. Detection of
cytomegalovirus interleukin 10 (cmvIL-10) by enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol. 2021;2244:291-299.
9. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl 1):S96-104.
10. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8(1):118-127.
11. Marcotte EL, Thomopoulos TP, Infante-Rivard C, et al. Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC). Lancet Haematol. 2016;3(4):e176-185.
12. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A. 2000;97(4):1695-1700.
13. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102.
14. Buxmann H, Hamprecht K, Meyer-Wittkopf M, Friese K. Primary human cytomegalovirus (HCMV) infection in pregnancy. Dtsch Arztebl Int. 2017;114(4):45-52.
15. Malek A, Sager R, Schneider H. Transport of proteins across the human placenta. Am J Reprod Immunol. 1998;40(5):347-351.
 Haematologica | 107 September 2022
2270















































































   269   270   271   272   273